Neo Ivy Capital Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.98M Buy
+193,906
New +$4.44M 0.92% 23
2025
Q4
– Sell
-93,260
Closed -$1.48M – 367
2025
Q3
$1.48M Buy
+93,260
New +$1.35M 0.36% 103
2025
Q1
– Sell
-57
Closed – – 301
2024
Q4
$0 Buy
+57
New +$1.11K ﹤0.01% 288
2023
Q4
$40K Buy
+1,264
New +$34.3K 0.09% 186
2022
Q4
– Sell
-6,700
Closed -$165K – 357
2022
Q3
$165K Buy
+6,700
New +$221K 0.43% 78
2021
Q1
– Sell
-1,535
Closed -$38K – 487
2020
Q4
$38K Buy
+1,535
New +$36.5K 0.04% 329

Other funds holding CC

Neo Ivy Capital Management's CC Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in Chemours (CC) in Q2 2026: 193,906 shares worth $3.98M. The stake represents 0.92% of the portfolio and ranks #23 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in CC as recently as Q3 2025.

Neo Ivy Capital Management first reported a position in CC in Q4 2020 and has held it in 6 quarters since. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Neo Ivy Capital Management held 193,906 shares of Chemours worth $3.98M as of Q2 2026.
  • Chemours was a new Neo Ivy Capital Management position in Q2 2026.
  • Chemours made up 0.92% of Neo Ivy Capital Management's portfolio in Q2 2026, its #23 holding.
  • Neo Ivy Capital Management first reported a position in Chemours in Q4 2020 and has held it in 6 quarters since.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.